Potassium Dysregulation in Patients with CKD
Kidney360 · 2025
DOI: 10.34067/kid.0000000903 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney360, 2025. Verfasst von Christopher Wilcox und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Georgetown University, Washington, DC. Hauptthemen laut MEDLINE: Hypokalemia, Renal Insufficiency, Chronic, Potassium, Potassium, Dietary. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hyperkalemia has long been the focus of potassium (K + ) dysregulation in patients with CKD. However, although the risks of hyperkalemia are well known and clearly important, there is growing evidence that hypokalemia occurs at least as frequently in those with CKD and is associated with an increase in all-cause or cardiovascular mortality as well as a faster progression of renal disease and earlier requirement for KRT. This is a brief review of low K + intake and hypokalemia in patients with CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Georgetown University, Washington, DC.
- Division of Endocrinology, Brigham and Women's Hospital, Harvard University, Boston, Massachusetts.
- Division of Cardiology, Department of Cardiology, University of Michigan, Ann Arbor, Michigan.
ORCID-Profile: Christopher Wilcox, Anand Vaidya, Bertram Pitt
Zitieren
APA
Wilcox, C., Vaidya, A., & Pitt, B. (2025). Potassium Dysregulation in Patients with CKD. Kidney360. https://doi.org/10.34067/kid.0000000903
Vancouver
Wilcox C, Vaidya A, Pitt B. Potassium Dysregulation in Patients with CKD. Kidney360. 2025. doi:10.34067/kid.0000000903
BibTeX
@article{Wilcox2025,
author = {Wilcox, Christopher and Vaidya, Anand and Pitt, Bertram},
title = {Potassium Dysregulation in Patients with CKD},
journal = {Kidney360},
year = {2025},
doi = {10.34067/kid.0000000903}
}
EUVIMED